FBLG

NASDAQ · Biotechnology

Fibrobiologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.05

-0.03 (-2.78%)

As of May 16, 9:43 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +1,827.6% upside

Low Target $14.74

Average Target $20.24

High Target $23.30

Current Price $1.05

Current
$1.05

Target
$20.24

$14.74 $20.24 avg $23.30

Scenario Analysis

Bear Case

$14.74

1,303.8%

Low target

Base Case

$20.24

+1,827.6%

Avg target

Bull Case

$23.30

+2,119.0%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$22.60

-95.4% from high

52-Week Low

$0.95

+10.3% from low

Target vs 52W High

$20.24

-10.4% vs high

Next Earnings Report

May 19, 2026

until earnings

EPS Est: $-1.33

Earnings in 2 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%